Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Oral peanut immunotherapy in children with peanut anaphylaxis.

Blumchen K, Ulbricht H, Staden U, Dobberstein K, Beschorner J, de Oliveira LC, Shreffler WG, Sampson HA, Niggemann B, Wahn U, Beyer K.

J Allergy Clin Immunol. 2010 Jul;126(1):83-91.e1. doi: 10.1016/j.jaci.2010.04.030. Epub 2010 Jun 12.

PMID:
20542324
2.

Allergen-specific oral immunotherapy for peanut allergy.

Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD009014. doi: 10.1002/14651858.CD009014.pub2. Review.

PMID:
22972130
3.

Successful oral tolerance induction in severe peanut allergy.

Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW.

Allergy. 2009 Aug;64(8):1218-20. doi: 10.1111/j.1398-9995.2009.01982.x. Epub 2009 Feb 17.

4.

Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy.

Nozawa A, Okamoto Y, Movérare R, Borres MP, Kurihara K.

Pediatr Allergy Immunol. 2014 Jun;25(4):323-8. doi: 10.1111/pai.12243.

PMID:
24953293
5.

Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome.

Anagnostou K, Clark A, King Y, Islam S, Deighton J, Ewan P.

Clin Exp Allergy. 2011 Sep;41(9):1273-81. doi: 10.1111/j.1365-2222.2011.03699.x. Epub 2011 Mar 18.

PMID:
21414048
6.

A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.

Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, Kulis M, Pons L, Vickery B, Burks AW.

J Allergy Clin Immunol. 2011 Mar;127(3):654-60. doi: 10.1016/j.jaci.2010.12.1111.

7.

Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.

Anagnostou K, Islam S, King Y, Foley L, Pasea L, Bond S, Palmer C, Deighton J, Ewan P, Clark A.

Lancet. 2014 Apr 12;383(9925):1297-304. doi: 10.1016/S0140-6736(13)62301-6. Epub 2014 Jan 30.

8.

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.

Narisety SD, Frischmeyer-Guerrerio PA, Keet CA, Gorelik M, Schroeder J, Hamilton RG, Wood RA.

J Allergy Clin Immunol. 2015 May;135(5):1275-82.e1-6. doi: 10.1016/j.jaci.2014.11.005. Epub 2014 Dec 18.

PMID:
25528358
9.

Egg oral immunotherapy in nonanaphylactic children with egg allergy.

Buchanan AD, Green TD, Jones SM, Scurlock AM, Christie L, Althage KA, Steele PH, Pons L, Helm RM, Lee LA, Burks AW.

J Allergy Clin Immunol. 2007 Jan;119(1):199-205. Epub 2006 Oct 27.

PMID:
17208602
10.

Clinical efficacy and immune regulation with peanut oral immunotherapy.

Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, Shreffler WG, Steele P, Henry KA, Adair M, Francis JM, Durham S, Vickery BP, Zhong X, Burks AW.

J Allergy Clin Immunol. 2009 Aug;124(2):292-300, 300.e1-97. doi: 10.1016/j.jaci.2009.05.022. Epub 2009 Jul 3.

11.

Administration of a probiotic with peanut oral immunotherapy: A randomized trial.

Tang ML, Ponsonby AL, Orsini F, Tey D, Robinson M, Su EL, Licciardi P, Burks W, Donath S.

J Allergy Clin Immunol. 2015 Mar;135(3):737-44.e8. doi: 10.1016/j.jaci.2014.11.034. Epub 2015 Jan 13.

PMID:
25592987
12.

Peanut oral immunotherapy: is it ready for clinical practice?

Sampson HA.

J Allergy Clin Immunol Pract. 2013 Jan;1(1):15-21. doi: 10.1016/j.jaip.2012.10.009. Epub 2012 Dec 27. Review.

PMID:
24229817
13.

Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.

Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW.

J Allergy Clin Immunol. 2014 Feb;133(2):468-75. doi: 10.1016/j.jaci.2013.11.007. Epub 2013 Dec 19.

14.

Rush specific oral tolerance induction in school-age children with severe egg allergy: one year follow up.

Itoh N, Itagaki Y, Kurihara K.

Allergol Int. 2010 Mar;59(1):43-51. doi: 10.2332/allergolint.09-OA-0107. Epub 2010 Nov 25.

15.

Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract.

Nelson HS, Lahr J, Rule R, Bock A, Leung D.

J Allergy Clin Immunol. 1997 Jun;99(6 Pt 1):744-51.

PMID:
9215240
16.

Oral and sublingual peanut immunotherapy is not ready for general use.

Greenhawt MJ.

Allergy Asthma Proc. 2013 May-Jun;34(3):197-204. doi: 10.2500/aap.2013.34.3661.

PMID:
23676568
17.

A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.

Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT.

J Allergy Clin Immunol. 2013 Dec;132(6):1368-74. doi: 10.1016/j.jaci.2013.09.046. Epub 2013 Oct 28.

18.

Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg-allergic children.

Vazquez-Ortiz M, Alvaro M, Piquer M, Dominguez O, Machinena A, Martín-Mateos MA, Plaza AM.

Clin Exp Allergy. 2014 Jan;44(1):130-41. doi: 10.1111/cea.12233.

PMID:
24355019
19.
20.

The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial.

Yu GP, Weldon B, Neale-May S, Nadeau KC.

Int Arch Allergy Immunol. 2012;159(2):179-82. doi: 10.1159/000336391. Epub 2012 Jun 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk